Dei BioPharma is at the forefront of revolutionizing African healthcare by pioneering biotech and pharmaceutical advancements. With a cutting-edge facility and a commitment to innovation, we aim to make high-quality medicines and vaccines accessible across the continent and beyond.
Dei Biopharma specializes in developing and manufacturing innovative medicines and vaccines. It was commissioned on July 6, 2021, by President Yoweri Museveni and Kenya President William Ruto (then Vice President).
While we are breaking ground as the first African biopharma company to enter Europe, the USA, and other developed markets, we remain committed to creating an impact in Africa and Uganda by creating jobs, pushing for sustainability, boosting healthcare access with affordable medicines, and growing talent through education and training programs.
This plant meets the world standards, at least the first bits that I have seen…. Local production is one of the ways of solving the problem of fake drugs so that the population consumes the right medicine.
Dei Biopharma Ltd is different from other foreign biotechnology companies such as Moderna that are being hosted by African countries.
Our leadership team combines decades of pharmaceuticals, biotechnology, and global healthcare expertise. Together, they lead DEI BioPharma in its mission to redefine healthcare for the better
Managing Director
Executive Director
Chief Executive Officer
Head of Human Capital
Dei Biopharma is always open to collaborations, partnerships, and inquiries. Whether you’re a healthcare provider, researcher, or global partner, we’d love to hear from you.
Abstract: The emergence of mRNA vaccine technology has revolutionized vaccine development, as demonstrated during the COVID-19 pandemic. With epitope-based design approaches,...
Abstract: MicroRNAs (miRNAs) maintain cellular homeostasis by blocking mRNAs by binding with them to fine-tune the expression of genes across...
Dr. Matthias Magoola Recognized at International Molecular Biologist Awards for Vaccine Research KAMPALA – Recognition for Groundbreaking Work in mRNA...
